Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Heideman

Showing results (71-80 of 272) with videos related to

Pageof 28
Sort By:
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|December 17, 2009
Dramatic response to low-dose erlotinib of epidermal growth factor receptor mutation-positive recurrent non-small cell lung cancer after severe cutaneous toxicityJoline S W Lind, Pieter E Postmus, Daniëlle A M Heideman, et al.
Tumour Virus Research|May 31, 2022
Women with a positive high-risk human papillomavirus (HPV) test remain at increased risk of HPV infection and cervical precancer ≥15 years laterFederica Inturrisi, Johannes A Bogaards, Albert G Siebers, et al.
The Journal of Molecular Diagnostics : JMD|December 15, 2019
Development and Validation of a Novel and Rapid Molecular Detection Method for High-Risk Human Papillomavirus in Formalin-Fixed, Paraffin-Embedded Tumor TissueSteven W Mes, Daniëlle A M Heideman, Elisabeth Bloemena, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 30, 2010
Bronchioloalveolar adenocarcinoma and pulmonary langerhans cell histiocytosis in a patient with MUTYH-associated polyposisJan H von der Thüsen, Marianne D van de Wetering, Anneke M Westermann, et al.
European Journal of Cancer (Oxford, England : 1990)|March 4, 2014
High-dose, weekly erlotinib is not an effective treatment in EGFR-mutated non-small cell lung cancer-patients with acquired extracranial progressive disease on standard dose erlotinibJ L Kuiper, D A M Heideman, E Thunnissen, et al.
British Journal of Cancer|November 7, 2021
Risk-stratification of HPV-positive women with low-grade cytology by FAM19A4/miR124-2 methylation and HPV genotypingStèfanie Dick, Frederique J Vink, Daniëlle A M Heideman, et al.
Journal of Clinical Microbiology|December 26, 2024
Optimization and analytical validation of the Allplex HPV28 genotyping assay for use in first-void urine samplesMargo Bell, Iacopo Baussano, MaryLuz Rol, et al.
European Journal of Cancer (Oxford, England : 1990)|July 26, 2011
Retreatment with erlotinib: Regain of TKI sensitivity following a drug holiday for patients with NSCLC who initially responded to EGFR-TKI treatmentA Becker, L Crombag, D A M Heideman, et al.
International Journal of Cancer|December 20, 2018
Management of HPV-positive women in cervical screening using results from two consecutive screening roundsNicole J Polman, Nienke J Veldhuijzen, Daniëlle A M Heideman, et al.
World Journal of Urology|July 9, 2008
Penile cancer: epidemiology, pathogenesis and preventionM C G Bleeker, D A M Heideman, P J F Snijders, et al.
Pageof 28

Showing results (71-80 of 272) with videos related to

Sort By:
Pageof 28
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|December 17, 2009
Dramatic response to low-dose erlotinib of epidermal growth factor receptor mutation-positive recurrent non-small cell lung cancer after severe cutaneous toxicityJoline S W Lind, Pieter E Postmus, Daniëlle A M Heideman, et al.
Tumour Virus Research|May 31, 2022
Women with a positive high-risk human papillomavirus (HPV) test remain at increased risk of HPV infection and cervical precancer ≥15 years laterFederica Inturrisi, Johannes A Bogaards, Albert G Siebers, et al.
The Journal of Molecular Diagnostics : JMD|December 15, 2019
Development and Validation of a Novel and Rapid Molecular Detection Method for High-Risk Human Papillomavirus in Formalin-Fixed, Paraffin-Embedded Tumor TissueSteven W Mes, Daniëlle A M Heideman, Elisabeth Bloemena, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 30, 2010
Bronchioloalveolar adenocarcinoma and pulmonary langerhans cell histiocytosis in a patient with MUTYH-associated polyposisJan H von der Thüsen, Marianne D van de Wetering, Anneke M Westermann, et al.
European Journal of Cancer (Oxford, England : 1990)|March 4, 2014
High-dose, weekly erlotinib is not an effective treatment in EGFR-mutated non-small cell lung cancer-patients with acquired extracranial progressive disease on standard dose erlotinibJ L Kuiper, D A M Heideman, E Thunnissen, et al.
British Journal of Cancer|November 7, 2021
Risk-stratification of HPV-positive women with low-grade cytology by FAM19A4/miR124-2 methylation and HPV genotypingStèfanie Dick, Frederique J Vink, Daniëlle A M Heideman, et al.
Journal of Clinical Microbiology|December 26, 2024
Optimization and analytical validation of the Allplex HPV28 genotyping assay for use in first-void urine samplesMargo Bell, Iacopo Baussano, MaryLuz Rol, et al.
European Journal of Cancer (Oxford, England : 1990)|July 26, 2011
Retreatment with erlotinib: Regain of TKI sensitivity following a drug holiday for patients with NSCLC who initially responded to EGFR-TKI treatmentA Becker, L Crombag, D A M Heideman, et al.
International Journal of Cancer|December 20, 2018
Management of HPV-positive women in cervical screening using results from two consecutive screening roundsNicole J Polman, Nienke J Veldhuijzen, Daniëlle A M Heideman, et al.
World Journal of Urology|July 9, 2008
Penile cancer: epidemiology, pathogenesis and preventionM C G Bleeker, D A M Heideman, P J F Snijders, et al.
Pageof 28